Literature DB >> 1630050

[Changes in pulmonary epithelial permeability due to thoracic irradiation].

Y Anazawa1, T Isawa, T Teshima, M Miki, M Motomiya.   

Abstract

The changes in pulmonary epithelial permeability during and following radiation therapy were studied in 10 patients with malignant diseases of the chest; 9 patients with bronchogenic carcinoma and one with thymoma. 99mTc-DTPA aerosol was inhaled during tidal breathing with the patient in supine position, and radioactivity was measured anteriorly by a gamma camera and recorded on a computer. Half time clearance (t1/2) was calculated from exponential fitting of time activity curves by regression analysis in various regions of interest in the initial 7 min following completion of aerosol inhalation. Studies were made every two weeks. In patients who developed radiation pneumonitis, t1/2 values decreased and reached the nadir at the time of manifest pneumonitis, indicating increased pulmonary epithelial permeability. Increased pulmonary epithelial permeability was observed not only in the pneumonic regions but also in the contralateral normal lung regions. Steroid therapy reversed these changes. Increased pulmonary epithelial permeability was observed in 2 out of 5 patients who did not develop radiation pneumonitis. In summary, pulmonary epithelial permeability changes occur not only in regions of radiation pneumonitis but also in non-irradiated lung regions following radiation therapy. We consider that the judicious use of this method enables detection of changes in pulmonary epithelial permeability prior to the development of clinical manifestations of radiation pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630050

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  1 in total

Review 1.  Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol.

Authors:  F X Sundram
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.